Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Global phylogeography and ancient evolution of the widespread human gut virus crAssphage.

Edwards RA, Vega AA, Norman HM, Ohaeri M, Levi K, Dinsdale EA, Cinek O, Aziz RK, McNair K, Barr JJ, Bibby K, Brouns SJJ, Cazares A, de Jonge PA, Desnues C, Díaz Muñoz SL, Fineran PC, Kurilshikov A, Lavigne R, Mazankova K, McCarthy DT, Nobrega FL, Reyes Muñoz A, Tapia G, Trefault N, Tyakht AV, Vinuesa P, Wagemans J, Zhernakova A, Aarestrup FM, Ahmadov G, Alassaf A, Anton J, Asangba A, Billings EK, Cantu VA, Carlton JM, Cazares D, Cho GS, Condeff T, Cortés P, Cranfield M, Cuevas DA, De la Iglesia R, Decewicz P, Doane MP, Dominy NJ, Dziewit L, Elwasila BM, Eren AM, Franz C, Fu J, Garcia-Aljaro C, Ghedin E, Gulino KM, Haggerty JM, Head SR, Hendriksen RS, Hill C, Hyöty H, Ilina EN, Irwin MT, Jeffries TC, Jofre J, Junge RE, Kelley ST, Khan Mirzaei M, Kowalewski M, Kumaresan D, Leigh SR, Lipson D, Lisitsyna ES, Llagostera M, Maritz JM, Marr LC, McCann A, Molshanski-Mor S, Monteiro S, Moreira-Grez B, Morris M, Mugisha L, Muniesa M, Neve H, Nguyen NP, Nigro OD, Nilsson AS, O'Connell T, Odeh R, Oliver A, Piuri M, Prussin Ii AJ, Qimron U, Quan ZX, Rainetova P, Ramírez-Rojas A, Raya R, Reasor K, Rice GAO, Rossi A, Santos R, Shimashita J, Stachler EN, Stene LC, Strain R, Stumpf R, Torres PJ, Twaddle A, Ugochi Ibekwe M, Villagra N, Wandro S, White B, Whiteley A, Whiteson KL, Wijmenga C, Zambrano MM, Zschach H, Dutilh BE.

Nat Microbiol. 2019 Jul 8. doi: 10.1038/s41564-019-0494-6. [Epub ahead of print]

PMID:
31285584
2.

Keeping crispr in check: diverse mechanisms of phage-encoded anti-crisprs.

Trasanidou D, Gerós AS, Mohanraju P, Nieuwenweg AC, Nobrega FL, Staals RHJ.

FEMS Microbiol Lett. 2019 May 1;366(9). pii: fnz098. doi: 10.1093/femsle/fnz098.

3.

Cas4-Cas1 fusions drive efficient PAM selection and control CRISPR adaptation.

Almendros C, Nobrega FL, McKenzie RE, Brouns SJJ.

Nucleic Acids Res. 2019 Jun 4;47(10):5223-5230. doi: 10.1093/nar/gkz217.

4.

Rational Identification of a Colorectal Cancer Targeting Peptide through Phage Display.

Ferreira D, Silva AP, Nobrega FL, Martins IM, Barbosa-Matos C, Granja S, Martins SF, Baltazar F, Rodrigues LR.

Sci Rep. 2019 Mar 8;9(1):3958. doi: 10.1038/s41598-019-40562-1.

5.

Incorporation of a Synthetic Amino Acid into dCas9 Improves Control of Gene Silencing.

Koopal B, Kruis AJ, Claassens NJ, Nobrega FL, van der Oost J.

ACS Synth Biol. 2019 Feb 15;8(2):216-222. doi: 10.1021/acssynbio.8b00347. Epub 2019 Jan 28.

PMID:
30668910
6.

Bowel Biofilms: Tipping Points between a Healthy and Compromised Gut?

Tytgat HLP, Nobrega FL, van der Oost J, de Vos WM.

Trends Microbiol. 2019 Jan;27(1):17-25. doi: 10.1016/j.tim.2018.08.009. Epub 2018 Sep 12. Review.

PMID:
30219265
7.

Molecular and Evolutionary Determinants of Bacteriophage Host Range.

de Jonge PA, Nobrega FL, Brouns SJJ, Dutilh BE.

Trends Microbiol. 2019 Jan;27(1):51-63. doi: 10.1016/j.tim.2018.08.006. Epub 2018 Sep 1. Review.

PMID:
30181062
8.

Targeting mechanisms of tailed bacteriophages.

Nobrega FL, Vlot M, de Jonge PA, Dreesens LL, Beaumont HJE, Lavigne R, Dutilh BE, Brouns SJJ.

Nat Rev Microbiol. 2018 Dec;16(12):760-773. doi: 10.1038/s41579-018-0070-8. Review.

PMID:
30104690
9.

Complete Genome Sequences of Two T4-Like Escherichia coli Bacteriophages.

Costa AR, Brouns SJJ, Nobrega FL.

Genome Announc. 2018 Jun 28;6(26). pii: e00586-18. doi: 10.1128/genomeA.00586-18.

10.

Exploiting Bacteriophage Proteomes: The Hidden Biotechnological Potential.

Santos SB, Costa AR, Carvalho C, Nóbrega FL, Azeredo J.

Trends Biotechnol. 2018 Sep;36(9):966-984. doi: 10.1016/j.tibtech.2018.04.006. Epub 2018 May 16. Review.

PMID:
29778530
11.

Cas4 Facilitates PAM-Compatible Spacer Selection during CRISPR Adaptation.

Kieper SN, Almendros C, Behler J, McKenzie RE, Nobrega FL, Haagsma AC, Vink JNA, Hess WR, Brouns SJJ.

Cell Rep. 2018 Mar 27;22(13):3377-3384. doi: 10.1016/j.celrep.2018.02.103.

12.

Complete Genome Sequence of the Escherichia coli Phage Ayreon.

Vlot M, Nobrega FL, Wong CFA, Liu Y, Brouns SJJ.

Genome Announc. 2018 Jan 11;6(2). pii: e01354-17. doi: 10.1128/genomeA.01354-17.

13.

Genetically manipulated phages with improved pH resistance for oral administration in veterinary medicine.

Nobrega FL, Costa AR, Santos JF, Siliakus MF, van Lent JW, Kengen SW, Azeredo J, Kluskens LD.

Sci Rep. 2016 Dec 15;6:39235. doi: 10.1038/srep39235.

14.

Screening and characterization of novel specific peptides targeting MDA-MB-231 claudin-low breast carcinoma by computer-aided phage display methodologies.

Nobrega FL, Ferreira D, Martins IM, Suarez-Diez M, Azeredo J, Kluskens LD, Rodrigues LR.

BMC Cancer. 2016 Nov 14;16(1):881.

15.

Selection of Novel Peptides Homing the 4T1 CELL Line: Exploring Alternative Targets for Triple Negative Breast Cancer.

Silva VL, Ferreira D, Nobrega FL, Martins IM, Kluskens LD, Rodrigues LR.

PLoS One. 2016 Aug 22;11(8):e0161290. doi: 10.1371/journal.pone.0161290. eCollection 2016.

16.

Revisiting phage therapy: new applications for old resources.

Nobrega FL, Costa AR, Kluskens LD, Azeredo J.

Trends Microbiol. 2015 Apr;23(4):185-91. doi: 10.1016/j.tim.2015.01.006. Epub 2015 Feb 21. Review.

PMID:
25708933
17.

Molecular aspects and comparative genomics of bacteriophage endolysins.

Oliveira H, Melo LD, Santos SB, Nóbrega FL, Ferreira EC, Cerca N, Azeredo J, Kluskens LD.

J Virol. 2013 Apr;87(8):4558-70. doi: 10.1128/JVI.03277-12. Epub 2013 Feb 13.

Supplemental Content

Loading ...
Support Center